Prime Minister Robert Abela on Thursday presented Malta's strategic vision to position itself as a leading European hub for MedTech, Life Sciences, and Digital Health. The Prime Minister affirmed that this national ambition is embodied is the Malta Vision 2050.
During his keynote speech at the MedTech World Malta 2025, Abela noted that Malta has introduced targeted incentives, support frameworks, and regulatory clarity designed to bring emerging technologies to market faster, without compromising on safety, ethics, or patient well-being.
MedTech World Malta 2025 is an annual event bringing together over 2,000 delegates, and expert speakers from around the world. With wide participation of startups, investors and government representatives from various countries including the US, the UK, Europe, the Middle East and Asia.
"True innovation flourishes when government, academia, industry, and healthcare providers work together in a single collaborative ecosystem," remarked Prime Minister Robert Abela. Institutions including Malta Enterprise, the Malta Life Sciences Park, the University of Malta, and the Ministry for Health are working in synergy to foster an environment in which new ideas can grow, scale, and deliver global impact. This collaborative approach is backed by strong investment in education and workforce development, aimed at nurturing the next generation of scientists, engineers, and digital health experts. He added that ongoing partnerships with international research institutions are assisting the country expand its talent pool in biotech, MedTech engineering, AI, and digital health.
Abela also referred to Malta's agility as a national testbed for digital health and real-world data platforms. Hospitals and clinics across the country are already rolling out projects in AI-driven diagnostics, telehealth, robotics, and digital hospital systems. These initiatives are not only improving patient outcomes but also demonstrating Malta's ability to innovate quickly.
Abela added that Malta is continuing to build strong international ties with research centres, hospitals, and MedTech companies. Public-private collaborations with the University of Malta and Mater Dei Hospital are helping turn scientific research into practical, market-ready healthcare solutions, he added. The Prime Minister stated that rising investors' interest, especially in oncology research and AI-powered diagnostics, strengthens Malta's reputation as a reliable EU base for high-value innovation.